Consistently, butein caused the increase of subG1 population in different breast cancer cells, whereas it did not accumulate luminal HER2+ HCC-1419, HCC-2218 and SKBR-3 breast cancer cells at subG1 phase (Figure 3D). This evidence concerns the gene ERBB2 and breast carcinoma.